INITIAL
Business purpose.
Activité R et D en santé. Travaux de biotechnologie végétale, animale et humaine et toute activité de production, d'analyse chimique, microbiologique.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Research and experimental development on biotechnology (72.11Z)
- Sector
- Scientific research and development
- Headcount
- Headcount unknown
- Created
- 19 Sep 2025
- Share capital
- 10,000.00 EUR
- Financial year end
- 31/12
- Establishments
- 2
Directors
- IRT President de SAS
Establishments
-
99209677600016 33360 QUINSAC
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
62 / 100 C
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (1.1 years)
- 2.1 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la fabrication et du commerce des produits à usage pharmaceutique, parapharmaceutique et vétérinaire du 1er juin 1989. Etendue par arrêté du 20 avril 1990 JORF 29 avril 1990
IDCC 1555 · repealed · 1 establishment · declared in July 2026
Legal notices
-
Amendment 11 Oct 2026
- Court :
- Greffe du Tribunal de Commerce de Bordeaux
- Amendment :
- transfert du siège social.
BODACC B n 20260195, annonce n 1307 · Proof of publication (PDF)
-
Incorporation 16 Oct 2025
- Court :
- Greffe du Tribunal de Commerce de Bordeaux
BODACC A n 20250199, annonce n 913 · Proof of publication (PDF)
Filings and accounts
- Formality 7 Oct 2026
- Formality 4 Nov 2025
- Formality 13 Oct 2025
Change history
- registered_address (empty) → 2 Chemin des Arestieux 33610 Cestas 12 Oct 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- capital (empty) → 10000.00 1 Oct 2026